A case report reveals misdiagnosis challenges in IgG4-related lymphadenopathy, highlighting the need for timely recognition and intervention.
Rationale: IgG4-related lymphadenopathy (IgG4-RLP), a challenging diagnostic entity within IgG4-related disease (IgG4-RD), often faces delays in treatment due to frequent misdiagnosis. Patient concerns: A 53-year-old male presented with a 4-year history of a right upper arm mass and axillary lymphadenopathy. Initial investigations suggested alternative diagnoses, resulting in a prior misdiagnosis of reactive lymph node hyperplasia. The patient presented with enlarged axillary lymph nodes. Imaging showed cortical thickening, loss of cortico-medullary differentiation, and homogeneous enhancement on CT. Routine lab results were unremarkable, but ultrasound revealed multiple enlarged lymph nodes. Diagnoses: A multidisciplinary approach, including core needle biopsy and retrospective analysis, confirmed systemic IgG4-RLP. The diagnosis included a unique “checkerboard-like” fibrosis pattern in a prior specimen, and elevated IgG4 levels. Interventions: The patient was treated with methylprednisolone. Outcomes: The patient experienced significant symptom relief, correlating with a decrease in serum IgG4 levels, after initiating steroid treatment, at a 2-week follow-up. Lessons: Diagnosing IgG4-RLP is challenging, especially when encountering atypical histological patterns such as “checkerboard-like” fibrosis. Therefore, unexplained lymphadenopathy characterized by increased plasma cells should prompt high suspicion for IgG4-RLP. Prompt recognition through integrated clinical and laboratory findings is crucial to prevent misdiagnosis and ensure timely intervention.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: